Bristol Myers Squibb Defies Patent Cliff: Blockbuster Sales of Opdivo and Eliquis Drive Raised Forecast
BMS crushed Q3 goals and boosted its yearly forecast. New blockbusters like Opdivo and Eliquis cover losses from older generic drugs.
NOTRELOAD AI
Why Tesla's Robotaxi Rollout Is Slowing Down
Tesla scaled back its robotaxi launch goals, but regulatory issues are causing further delays. Learn about the missing paperwork and why drivers are still needed in California.
Boeing Tumbles as Trump-Xi Deal Disappoints on Aircraft Orders, Deutsche Bank Cuts Rating
Boeing stock falls after Trump-Xi meeting fails to produce aircraft purchase agreement. Deutsche Bank downgrades to "hold" citing cash flow concerns and legacy burdens constraining recovery.
Moderna Explores Major Deal Options, Including Potential Buyout
Moderna is in discussions with large pharmaceutical companies about significant deals, including a possible buyout.
Core Scientific and CoreWeave Merger Is Off: What Happened?
Core Scientific shareholders rejected the merger with AI company CoreWeave. The deal is terminated, but their business partnership continues.
Altria Forecasts a Modest Annual Profit due to Sluggish Tobacco Demand
Altria Group (MO) reports Q3 profit of $2.38B despite 3% revenue decline. Tobacco giant beats earnings expectations but faces vaping challenges and declining cigarette demand.